Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Bevacizumab in Inflammatory Eye Disease
American Journal of Ophthalmology, 08/06/09
Lott MN et al. – For eyes with CNV, BCVA improved significantly at follow–up month 1, but was not different from baseline thereafter; CST remained unchanged throughout follow–up. For eyes with CME, neither BCVA nor CST changed significantly over the course of follow–up. Bevacizumab appears to stabilize BCVA and CST for eyes with inflammatory CNV or CME.
Related Articles
Analysis of Inflammatory Cytokines in the Tears of Dry Eye Patients
Cornea, 10/14/09
Relevance Score: 81%
Update on thyroid eye disease and management
Clinical Ophthalmology, 10/19/09
Relevance Score: 80%
Cyclosporine helps revent progression of dry eye
Ophthalmology Times Europe, 10/08/09
Relevance Score: 80%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 70%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 70%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09
Exploratory Analysis of Diabetic Retinopathy Progression Through 3 Years in a Randomized Clinical Trial That Compares Intravitreal Triamcinolone Acetonide With Focal/Grid Photocoagulation
Archives of Ophthalmology, 12/18/09
Alterations in the Intraocular Cytokine Milieu Following Intravitreal Bevacizumab
Investigative Ophthalmology and Visual Science, 12/17/09
Article Search
Sponsor


See Latest Articles


